Maureen L. Groot Koerkamp
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Maureen L. Groot Koerkamp has a total of 106 co-authors. Here are the top co-authors by number of shared publications:
Antonetta C. Houweling
UMC Utrecht, Dept Radiotherapy, Utrecht, Netherlands
3 shared publications- Anna M. Kirby
Royal Marsden NHS Foundation Trust, Sutton, UK
2 shared publications - Antonetta Christina Houweling
Department of Radiotherapy, University Medical Center Utrecht, the Netherlands
2 shared publications - Bas W. Raaymakers
Department of Radiotherapy, University Medical Center Utrecht, the Netherlands
2 shared publications Bram van Asselen
Department of Radiation Oncology, UMC Utrecht, Utrecht, the Netherlands
2 shared publications- Dennis Winkel
Department of Radiotherapy, University Medical Center, Utrecht, The Netherlands
2 shared publications
Latest Publications
- Open Access
- 15 September 2024
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 200, 110541
Automated dose evaluation on daily cone-beam computed tomography for breast cancer patients
- 15 September 2024
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 200, 110541
Open AccessAutomated dose evaluation on daily cone-beam computed tomography for breast cancer patients
- Open Access
- 7 June 2024
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 31, 100597
Bringing online adaptive radiotherapy to a standard C-arm linac
- 7 June 2024
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 31, 100597
Open AccessBringing online adaptive radiotherapy to a standard C-arm linac
- 21 March 2024
- Published by Springer Nature
- p. 307-321
Breast Radiotherapy Using MR-Linac
- 24 July 2023
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 182, S1695-S1696
PO-1940 Online adaptive CBCT-guided VMAT radiotherapy using an Elekta Synergy CBCT-linac
- 24 July 2023
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 182, S1695-S1696
PO-1940 Online adaptive CBCT-guided VMAT radiotherapy using an Elekta Synergy CBCT-linac
- Open Access
- 5 July 2022
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 23, 74-79
Intrafraction motion during radiotherapy of breast tumor, breast tumor bed, and individual axillary lymph nodes on cine magnetic resonance imaging
- 5 July 2022
- Published by Elsevier in Physics and Imaging in Radiation Oncology
- Vol. 23, 74-79
Open AccessIntrafraction motion during radiotherapy of breast tumor, breast tumor bed, and individual axillary lymph nodes on cine magnetic resonance imaging
- Open Access
- 1 December 2021
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 165, 193-199
Prone vs. supine accelerated partial breast irradiation on an MR-Linac: A planning study
- 1 December 2021
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 165, 193-199
Open AccessProne vs. supine accelerated partial breast irradiation on an MR-Linac: A planning study
- Open Access
- 20 November 2021
- Published by Elsevier in Advances in Radiation Oncology
- Vol. 7 (2) , 100854
Dynamic Contrast-enhanced and Diffusion-weighted Magnetic Resonance Imaging for Response Evaluation After Single-Dose Ablative Neoadjuvant Partial Breast Irradiation
- 20 November 2021
- Published by Elsevier in Advances in Radiation Oncology
- Vol. 7 (2) , 100854
Open AccessDynamic Contrast-enhanced and Diffusion-weighted Magnetic Resonance Imaging for Response Evaluation After Single-Dose Ablative Neoadjuvant Partial Breast Irradiation
- 16 April 2021
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 66 (8) , 085010
Synthetic CT for single-fraction neoadjuvant partial breast irradiation on an MRI-linac
A synthetic computed tomography (sCT) is required for daily plan optimization on an MRI-linac. Yet, only limited information is available on the accuracy of dose calculations on sCT for breast radiotherapy. This work aimed to (1) evaluate dosimetric accuracy of treatment plans for single-fraction neoadjuvant partial breast irradiation (PBI) on a 1.5 T MRI-linac calculated on a) bulk-density sCT mimicking the current MRI-linac workflow and b) deep learning-generated sCT, and (2) investigate the number of bulk-density levels required. For ten breast cancer patients we created three bulk-density sCTs of increasing complexity from the planning-CT, using bulk-density for: (1) body, lungs, and GTV (sCT BD1 ); (2) volumes for sCT BD1 plus chest wall and ipsilateral breast (sCT BD2 ); (3) volumes for sCT BD2 plus ribs (sCT BD3 ); and a deep learning-generated sCT (sCT DL ) from a 1.5 T MRI in supine position. Single-fraction neoadjuvant PBI treatment plans for a 1.5 T MRI-linac were optimized on each sCT and recalculated on the planning-CT. Image evaluation was performed by assessing mean absolute error (MAE) and mean error (ME) in Hounsfield Units (HU) between the sCTs and the planning-CT. Dosimetric evaluation was performed by assessing dose differences, gamma pass rates, and dose-volume histogram (DVH) differences. The following results were obtained (median across patients for sCT BD1 /sCT BD2 /sCT BD3 /sCT DL respectively): MAE inside the body contour was 106/104/104/75 HU and ME was 8/9/6/28 HU, mean dose difference in the PTV GTV was 0.15/0.00/0.00/−0.07 Gy, median gamma pass rate (2%/2 mm, 10% dose threshold) was 98.9/98.9/98.7/99.4%, and differences in DVH parameters were well below 2% for all structures except for the skin in the sCT DL . Accurate dose calculations for single-fraction neoadjuvant PBI on an MRI-linac could be performed on both bulk-density and deep learning sCT, facilitating further implementation of MRI-guided radiotherapy for breast cancer. Balancing simplicity and accuracy, sCT BD2 showed the optimal number of bulk-density levels for a bulk-density approach.
- 16 April 2021
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 66 (8) , 085010
Synthetic CT for single-fraction neoadjuvant partial breast irradiation on an MRI-linac
A synthetic computed tomography (sCT) is required for daily plan optimization on an MRI-linac. Yet, only limited information is available on the accuracy of dose calculations on sCT for breast radiotherapy. This work aimed to (1) evaluate dosimetric accuracy of treatment plans for single-fraction neoadjuvant partial breast irradiation (PBI) on a 1.5 T MRI-linac calculated on a) bulk-density sCT mimicking the current MRI-linac workflow and b) deep learning-generated sCT, and (2) investigate the number of bulk-density levels required. For ten breast cancer patients we created three bulk-density sCTs of increasing complexity from the planning-CT, using bulk-density for: (1) body, lungs, and GTV (sCT BD1 ); (2) volumes for sCT BD1 plus chest wall and ipsilateral breast (sCT BD2 ); (3) volumes for sCT BD2 plus ribs (sCT BD3 ); and a deep learning-generated sCT (sCT DL ) from a 1.5 T MRI in supine position. Single-fraction neoadjuvant PBI treatment plans for a 1.5 T MRI-linac were optimized on each sCT and recalculated on the planning-CT. Image evaluation was performed by assessing mean absolute error (MAE) and mean error (ME) in Hounsfield Units (HU) between the sCTs and the planning-CT. Dosimetric evaluation was performed by assessing dose differences, gamma pass rates, and dose-volume histogram (DVH) differences. The following results were obtained (median across patients for sCT BD1 /sCT BD2 /sCT BD3 /sCT DL respectively): MAE inside the body contour was 106/104/104/75 HU and ME was 8/9/6/28 HU, mean dose difference in the PTV GTV was 0.15/0.00/0.00/−0.07 Gy, median gamma pass rate (2%/2 mm, 10% dose threshold) was 98.9/98.9/98.7/99.4%, and differences in DVH parameters were well below 2% for all structures except for the skin in the sCT DL . Accurate dose calculations for single-fraction neoadjuvant PBI on an MRI-linac could be performed on both bulk-density and deep learning sCT, facilitating further implementation of MRI-guided radiotherapy for breast cancer. Balancing simplicity and accuracy, sCT BD2 showed the optimal number of bulk-density levels for a bulk-density approach.
- Open Access
- 28 July 2020
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 10, 1107
Optimizing MR-Guided Radiotherapy for Breast Cancer Patients
Current research in radiotherapy (RT) for breast cancer is evaluating neoadjuvant as opposed to adjuvant partial breast irradiation (PBI) with the aim of reducing the volume of breast tissue irradiated and therefore the risk of late treatment-related toxicity. The development of magnetic resonance (MR)–guided RT, including dedicated MR-guided RT systems [hybrid machines combining an MR scanner with a linear accelerator (MR-linac) or 60Co sources], could potentially reduce the irradiated volume even further by improving tumour visibility before and during each RT treatment. In this position paper, we discuss MR guidance in relation to each step of the breast RT planning and treatment pathway, focusing on the application of MR-guided RT to neoadjuvant PBI.
- 28 July 2020
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 10, 1107
Open AccessOptimizing MR-Guided Radiotherapy for Breast Cancer Patients
Current research in radiotherapy (RT) for breast cancer is evaluating neoadjuvant as opposed to adjuvant partial breast irradiation (PBI) with the aim of reducing the volume of breast tissue irradiated and therefore the risk of late treatment-related toxicity. The development of magnetic resonance (MR)–guided RT, including dedicated MR-guided RT systems [hybrid machines combining an MR scanner with a linear accelerator (MR-linac) or 60Co sources], could potentially reduce the irradiated volume even further by improving tumour visibility before and during each RT treatment. In this position paper, we discuss MR guidance in relation to each step of the breast RT planning and treatment pathway, focusing on the application of MR-guided RT to neoadjuvant PBI.